Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

The Weiss score and beyond--histopathology for adrenocortical carcinoma.

Papotti M, Libè R, Duregon E, Volante M, Bertherat J, Tissier F.

Horm Cancer. 2011 Dec;2(6):333-40. doi: 10.1007/s12672-011-0088-0. Review.

2.

Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases.

Duregon E, Volante M, Cappia S, Cuccurullo A, Bisceglia M, Wong DD, Spagnolo DV, Szpak-Ulczok S, Bollito E, Daffara F, Berruti A, Terzolo M, Papotti M.

Am J Surg Pathol. 2011 Dec;35(12):1882-93. doi: 10.1097/PAS.0b013e31822da401.

3.

The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases.

Duregon E, Fassina A, Volante M, Nesi G, Santi R, Gatti G, Cappellesso R, Dalino Ciaramella P, Ventura L, Gambacorta M, Dei Tos AP, Loli P, Mannelli M, Mantero F, Berruti A, Terzolo M, Papotti M.

Am J Surg Pathol. 2013 Sep;37(9):1433-40. doi: 10.1097/PAS.0b013e31828d387b.

4.

Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification.

Volante M, Bollito E, Sperone P, Tavaglione V, Daffara F, Porpiglia F, Terzolo M, Berruti A, Papotti M.

Histopathology. 2009 Nov;55(5):535-43. doi: 10.1111/j.1365-2559.2009.03423.x.

5.

Pathological and molecular features of adrenocortical carcinoma: an update.

Volante M, Buttigliero C, Greco E, Berruti A, Papotti M.

J Clin Pathol. 2008 Jul;61(7):787-93. doi: 10.1136/jcp.2007.050625. Epub 2008 Apr 22. Review.

PMID:
18430754
6.

Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates.

Duregon E, Volante M, Giorcelli J, Terzolo M, Lalli E, Papotti M.

Hum Pathol. 2013 May;44(5):822-8. doi: 10.1016/j.humpath.2012.07.025. Epub 2012 Nov 14.

7.

Histopathological diagnosis and prognostic factors in adrenocortical carcinoma.

Aiba M, Fujibayashi M.

Endocr Pathol. 2005 Spring;16(1):13-22.

PMID:
16000842
8.
9.

[Weiss system: a still in-use diagnostic tool for the assessment of adrenocortical malignancy].

Aubert S, Buob D, Leroy X, Devos P, Carnaille B, Do Cao C, Wemeau JL, Leteurtre E.

Ann Pathol. 2005 Dec;25(6):545-54. Review. French.

PMID:
16735978
10.

Classification of adrenal cortical tumors: what limits for the pathological approach?

Tissier F.

Best Pract Res Clin Endocrinol Metab. 2010 Dec;24(6):877-85. doi: 10.1016/j.beem.2010.10.011. Review.

PMID:
21115156
11.

Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas.

Volante M, Sperone P, Bollito E, Frangipane E, Rosas R, Daffara F, Terzolo M, Berruti A, Papotti M.

Mod Pathol. 2006 Dec;19(12):1563-9. Epub 2006 Sep 15.

12.

Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors.

Aubert S, Wacrenier A, Leroy X, Devos P, Carnaille B, Proye C, Wemeau JL, Lecomte-Houcke M, Leteurtre E.

Am J Surg Pathol. 2002 Dec;26(12):1612-9.

PMID:
12459628
13.

Pediatric adrenocortical tumors: morphological diagnostic criteria and immunohistochemical expression of matrix metalloproteinase type 2 and human leucocyte-associated antigen (HLA) class II antigens. Results from the Italian Pediatric Rare Tumor (TREP) Study project.

Magro G, Esposito G, Cecchetto G, Dall'Igna P, Marcato R, Gambini C, Boldrini R, Collini P, D'Onofrio V, Salfi N, d'Amore E, Ferrari A, Bisogno G, Alaggio R.

Hum Pathol. 2012 Jan;43(1):31-9. doi: 10.1016/j.humpath.2011.04.016. Epub 2011 Aug 4.

PMID:
21820153
14.

Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants.

de Krijger RR, Papathomas TG.

Virchows Arch. 2012 Jan;460(1):9-18. doi: 10.1007/s00428-011-1166-y. Epub 2011 Nov 16. Review.

15.

Adrenocortical oncocytic tumors: report of 10 cases and review of the literature.

Bisceglia M, Ludovico O, Di Mattia A, Ben-Dor D, Sandbank J, Pasquinelli G, Lau SK, Weiss LM.

Int J Surg Pathol. 2004 Jul;12(3):231-43.

PMID:
15306935
16.

Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability.

Blanes A, Diaz-Cano SJ.

Am J Clin Pathol. 2007 Mar;127(3):398-408.

PMID:
17276949
17.

Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB.

Vargas MP, Vargas HI, Kleiner DE, Merino MJ.

Am J Surg Pathol. 1997 May;21(5):556-62.

PMID:
9158680
19.

Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.

Pennanen M, Heiskanen I, Sane T, Remes S, Mustonen H, Haglund C, Arola J.

Hum Pathol. 2015 Mar;46(3):404-10. doi: 10.1016/j.humpath.2014.11.015. Epub 2014 Dec 9.

PMID:
25582500
20.

Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.

Wick MR, Cherwitz DL, McGlennen RC, Dehner LP.

Am J Pathol. 1986 Feb;122(2):343-52.

Supplemental Content

Support Center